DG Health Triple Antibiotic (Dolgencorp Inc)
Welcome to the PulseAid listing for the DG Health Triple Antibiotic drug offered from Dolgencorp Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dolgencorp Inc |
NON-PROPRIETARY NAME: | bacitracin, neomycin, polymyxin B |
SUBSTANCE NAME: | BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | OINTMENT |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2010-02-07 |
END MARKETING DATE: | 0000-00-00 |
DG Health Triple Antibiotic HUMAN OTC DRUG Details:
Item Description | DG Health Triple Antibiotic from Dolgencorp Inc |
LABELER NAME: | Dolgencorp Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400; 3.5; 5000([USP’U]/g; mg/g; [USP’U]/g) |
START MARKETING DATE: | 2010-02-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55910-067_9ecd0226-feba-41ab-bceb-a4cf1ebfa027 |
PRODUCT NDC: | 55910-067 |
APPLICATION NUMBER: | part333 |
Other BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers: